• #ATS2018 — Bellerophon Presenting Top-line Results Showing INOpulse’s Benefits in PH-COPD Patients
  • Feeling Pulmonary Hypertension’s Impact Beyond the Lungs
  • Team PHenomenal Hope Provides Renewable Power to Puerto Ricans
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • Sarcoidosis Patients with PH in US Less Likely To Be Treated Than Those Living Elsewhere, Study Finds
  • Scottish Agency Recommends Uptravi for PAH Treatment Through National Health System
  • So, How Are Your 30s Going?
  • Reata Recruiting More CTD-PAH Patients for Phase 3 CATALYST Trial Testing Bardoxolone Methyl
  • When Pulmonary Hypertension Causes Weight Fluctuations
  • Enzyme Involved in Energy Production May Become New Target for Early Stage PH Therapy
  • INOpulse Therapy for PH Associated with COPD to Enter Phase 2b Trial in US